However, updated HAE management guidelines recommend a genetic-based diagnosis to increase the diagnostic yield and reduce the diagnosis delay in those patients with HAE Type II and HAE-nC1-INH, as well in those cases with highly suspicious of HAE Type I diagnosis and negative family history [11,21]. This evidence concerns the gene COL18A1 and hereditary angioedema.